This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact.

This book provides comprehensive information on transcatheter aortic valve implantation (TAVI), which was introduced for the treatment of aortic valve disease less than two decades ago. It explains how TAVI has delivered satisfactory results even in high and intermediate risk patients and outlines how it continues to evolve, thus requiring awareness of state of the art approaches to indication, risk stratification, device choice, procedure, and follow-up. In addition, it reports on the complex and multidisciplinary approach needed to maximize the efficacy, safety, and appropriateness of TAVI, providing detailed clinical, interventional and surgical perspectives focusing on the development of this cardiovascular intervention. Starting with the history of TAVI, addressing the interventional anatomy of aortic valve disease, and reporting on the expert authors’ day-to-day experiences, this highly informative book offers an essential update for all cardiologists and surgeons interested in transcatheter aortic valve implantation, as well as any clinician, decision-maker and stakeholder involved in patient selection, procedural management, and follow-up.

To help you optimize your exam performance, members of the Society for Cardiovascular Angiography and Interventions (SCAI), have created a fully revised and updated Second Edition of the SCAI Interventional Cardiology Board Review—a comprehensive yet concise review for board certification and recertification exams in interventional cardiology.

Covering the full range of diagnosis and treatment for valvular heart disease, this award-winning reference provides the information you need for safe and effective practice. Part of the Brauwald's family of heart disease references, Valvular Heart Disease, 5th Edition, brings you fully up to date with the latest procedures, imaging modalities, basic science, diagnostic criteria, and treatment guidelines in this fast-changing area. Internationally renowned authors Dr. Catherine M. Otto and Dr. Robert O. Bonow help you apply today's best, evidence-based medical and surgical approaches in your daily practice. - Covers current topics such as transcatheter aortic valve replacement (TAVR), timing of intervention for mitral regurgitation, imaging guidance of transcatheter valve procedures, management of prosthetic valve, advanced imaging of the aortic and mitral valves, management of valve disease in pregnant women, and advances in diagnosis and treatment of endocarditis. - Contains new chapters on the imaging approach before TAVR, transcatheter valve-in-valve implantation for prosthetic valve stenosis, and management of pulmonic valve disease. - Provides summaries of ACC, AHA, and ESC guidelines for guidance on best practices. - Includes all the latest imaging modalities for a full understanding of tools needed for the most accurate physiologic understanding and accurate diagnoses. - Offers access to 80 videos that help you visualize heart valve anatomy and dysfunction, as well as important techniques and procedures. - Features an extensive number of new and updated illustrations of anatomy and physiology, methodology, flow charts, and clinical examples—750 high-quality images in all. - Reorganizes chapters to closely link imaging and interventional approaches for aortic and mitral valve disease. - Emphasizes evidence-based approaches with outcome data and relevant references. - 2014 BMA Medical Book Awards 1st Prize Award Winner in Cardiology category.

Calcific aortic valve stenosis is the most frequent valvular heart disease in Western countries, affecting up to 13% of individuals over 75 years. The disease is associated with considerable morbidity and mortality. It is characterized by fibro-calcification of aortic valve cusps and concomitant left ventricular remodelling due to chronic pressure overload, which can evolve into overt heart failure. It progresses very slowly until the onset of symptoms, the indication for aortic valve replacement. Today, about 300,000 aortic valve replacements are performed annually worldwide, either via surgery or transcatheter implantation. This is the only treatment shown to improve survival. There is no pharmacological treatment to prevent or slow disease progression. Major risk factors include older age, congenital anomalies of the aortic valve (bicuspid valve), male gender, hypertension, dyslipidaemia, smoking, and diabetes. However, how these factors contribute to the disease in unclear. Due to the disease itself, patients are at increased risk of both thrombosis and bleeding, which, in addition to advanced age and comorbidities, makes antithrombotic management of these patients difficult. Regarding valve prostheses, the ideal prosthesis either mechanical or biological still does not exist. Clinically available prostheses can lead to major complications, thrombosis or infection, which necessitate reoperation or cause death in 50-60% of patients within 10 years post-implantation. Hence, there are major unmet medical needs in CAVS and more basic and translational research is definitely required. Our Research Topic depicts major challenges and research paths that could be followed to address these major health needs.